Issue 21, 2022

Transformable nanoparticles to bypass biological barriers in cancer treatment

Abstract

Nanomedicine based drug delivery platforms provide an interesting avenue to explore for the future of cancer treatment. Here we discuss the barriers for drug delivery in cancer therapeutics and how nanomaterials have been designed to bypass these blockades through stimuli responsive transformation in the most recent update. Nanomaterials that address the challenges of each step provide a promising solution for new cancer therapeutics.

Graphical abstract: Transformable nanoparticles to bypass biological barriers in cancer treatment

Article information

Article type
Minireview
Submitted
27 Jūl. 2022
Accepted
03 Sept. 2022
First published
14 Sept. 2022
This article is Open Access
Creative Commons BY license

Nanoscale Adv., 2022,4, 4470-4480

Transformable nanoparticles to bypass biological barriers in cancer treatment

M. Ramachandran, Z. Ma, K. Lin, C. De Souza and Y. Li, Nanoscale Adv., 2022, 4, 4470 DOI: 10.1039/D2NA00485B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements